doi: 10.1161/01.hyp.8.4.344
It is escalating your current dose
Int J Mol Sci 2020;21:5888
particularly, we added language that explicitly stated that firms that had terminated retiree health benefits but still has some retirees currently getting coverage, or that had current employees who will get retiree health coverage in the future, should answer yes to the question
568 15.1 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 574 15.2 CUSTOMIZATION OPTIONS 576 TABLE 1 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: INCLUSIONS AND EXCLUSIONS 50 TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS 64 TABLE 3 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: RISK ANALYSIS 67 TABLE 4 PHARMACEUTICAL API MANUFACTURING SERVICES MARKET, BY REGION, 20232030 (USD BILLION) 80 TABLE 5 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 83 TABLE 6 ABBREVIATED NEW DRUG APPLICATION (ANDA) APPROVAL, 2024 87 TABLE 7 EUROPEAN DIRECTORATE FOR QUALITY OF MEDICINES & HEALTHCARE CERTIFICATE OF SUITABILITY TO MONOGRAPHS OF EUROPEAN PHARMACOPOEIA (EDQM CEP) CERTIFICATION ACTIVITY, 2024 88 TABLE 8 INDICATIVE PRICING OF ACTIVE PHARMACEUTICAL INGREDIENTS, BY KEY PLAYER, 2024 (USD) 94 TABLE 9 INDICATIVE PRICING ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2024 (USD) 95 TABLE 10 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: ROLE IN ECOSYSTEM 103 TABLE 11 ACTIVE PHARMACEUTICAL INGREDIENTS: KEY CONFERENCES & EVENTS, 20252026 104 TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 108 TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 108 TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 109 TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110 TABLE 16 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110 TABLE 17 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: PORTERS FIVE FORCES 111 TABLE 18 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE (%) 113 TABLE 19 BUYING CRITERIA FOR ACTIVE PHARMACEUTICAL INGREDIENTS, BY END USER 114 TABLE 20 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: CASE STUDY ANALYSIS 115 TABLE 21 HEALTH EXPENDITURE AND FINANCING, 20152024 (IN PERCENTAGE OF GDP) 116 TABLE 22 CANCER INCIDENCE, BY REGION, 2022 118 TABLE 23 NUMBER OF PATENTS FILED IN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, 20142024 119 TABLE 24 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: LIST OF PATENTS, 2023 120 TABLE 25 IMPORT DATA FOR ANTIBIOTICS HS CODE2941, 2020-2024, VALUE (USD) 121 TABLE 26 IMPORT DATA FOR ANTIBIOTICS HS CODE2941, 2020-2024, VOLUME (TONS) 121 TABLE 27 IMPORT DATA FOR NUCLEIC ACIDS AND THEIR SALTS, WHETHER OR NOT CHEMICALLY DEFINED
